Theriva Biologics, Inc. (TOVX): Depreciation & Amortization
$108.0K
Year ended 2025-12-31
$103.0K
Trailing 12 months to 2026-06-30
+8.3%
3-year compound annual growth
-11.7%
5-year compound annual growth
+4.1%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $108.0K | -21.2% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $137.0K | +1.5% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $135.0K | +58.8% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | $85.0K | -2.3% | 2024-03-25, From 2022-01-01 |
| 2021-12-31 | $87.0K | -56.7% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $201.0K | -16.3% | 2022-03-16, From 2020-01-01 |
| 2019-12-31 | $240.0K | -11.8% | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | $272.0K | +11.0% | 2020-02-20, From 2018-01-01 |
| 2017-12-31 | $245.0K | +56.1% | 2019-02-27, From 2017-01-01 |
| 2016-12-31 | $157.0K | +118.1% | 2018-02-22, From 2016-01-01 |
| 2015-12-31 | $72.0K | +260.0% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $20.0K | -53.5% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $43.0K | n/a | 2016-03-10, From 2013-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Theriva Biologics, Inc. (TOVX) | 2025-12-31 | $108.0K | -21.2% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $1.91M | +0.7% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $384.0K | -24.6% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $73.7K | -10.5% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $958.0K | +141.3% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.63M | n/m |
| Tvardi Therapeutics, Inc. (TVRD) | 2025-12-31 | $95.0K | 0.0% |
| Medicinova Inc (MNOV) | 2025-12-31 | $20.1K | -4.6% |
| Valion Bio, Inc. (VBIO) | 2024-12-31 | $3.0K | -62.5% |
Compare TOVX, JAGX, TXMD, SXTC side by side · Screen every company in Pharmaceutical Preparations ↗